title: How much will Herceptin really cost?
authors.affiliation: Department of Oncology, Norfolk and Norwich University Hospital NHS Trust, Norwich NR4 7UY. ann.barrett@uea.ac.uk
authors.forename: Ann
authors.initials: A
authors.lastname: Barrett
authors.forename: Tom
authors.initials: T
authors.lastname: Roques
authors.forename: Matthew
authors.initials: M
authors.lastname: Small
authors.forename: Richard D
authors.initials: RD
authors.lastname: Smith
mesh_terms: D000911:Antibodies, Monoclonal / Q000191:economics* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000191:economics; D017024:Chemotherapy, Adjuvant / Q000191:economics; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D005260:Female; D006801:Humans; D000068878:Trastuzumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab